Contact Kessler Topaz Meltzer & Check, LLP About Securities Class Action Against DENTSPLY SIRONA Inc. (XRAY) Investing.com
RADNOR, PA–(NewMediaWire)–December 28, 2024–The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that against DENTSPLY SIRONA (NASDAQ:) Inc . (DENTSPLY) (NASDAQ: XRAY ) on behalf of those who purchased or otherwise acquired DENTSPLY common stock between and including May 6, 2021 and November 6, 2024 (Teaching Period). The deadline for the chief prosecutor is January 27, 2025.
CONTACT KESSLER TOPAZ MELTZER & CHECK, LLP:
If you have suffered DENTSPLY losses, you can CLICK HERE or copy and paste this link into your browser: https://www.ktmc.com/new-cases/dentsply-sirona-inc?utm_source=PR&utm_medium=link&utm_campaign=xray&mktm=r
You may also contact attorney Jonathan Naji, Esq. by calling (484) 270-1453 or emailing info@ktmc.com.
ALLEGED MISCONDUCT OF THE ACCUSED:
The complaints allege that throughout the Class Period, Defendants made false and/or misleading statements and/or failed to disclose the following: (1) DENTSPLY targeted low-income people who did not have access to good oral hygiene education, a dentist, or dental insurance , which often meant that patients who signed up for Byte, a direct-to-consumer straightening solution, had underlying dental problems that would make them ineligible for treatment; (2) the incentive for Byte’s growth and sales commissions induced sales employees to sell to contraindicated patients; (3) as a result of the foregoing, Byte’s patient enrollment workflow did not provide adequate assurance that contraindicated patients did not enter treatment; (4) before and during class, reports of patient injuries at Byte poured in; (5) DENTSPLY knew that its Byte aligners were causing serious patient injuries for years, but did little to investigate those injuries or notify the FDA; (6) DENTSPLY did not have a system in place to notify the FDA of these injuries, which Dentsply is required to do within 30 days of becoming aware of the problem; (7) the FDA received a sharp increase in reports of serious injuries from Byte patients; (8) as a result of the above, DENTSPLY significantly overstated the value of Byte’s goodwill; and (9) as a result of the foregoing, Defendants’ positive statements about DENTSPLY’s business, operations and prospects were materially false and misleading and/or lacked a reasonable basis at all relevant times.
PROCEDURE OF THE CHIEF PROSECUTOR:
DENTSPLY’s investors may, no later than January 27, 2025, seek to be appointed lead plaintiff, class representative through Kessler Topaz Meltzer & Check, LLP or other counsel, or may choose to do nothing and remain an absent class member. The lead plaintiff is the representative party that acts on behalf of all class members in the conduct of the litigation. The lead plaintiff is usually an investor or a small group of investors who have the greatest financial interest and who are also appropriate and typical of the proposed class of investors. The lead plaintiff selects counsel to represent the lead plaintiff and the class and those attorneys, if approved by the court, are lead or class counsel. Deciding whether or not to be the lead claimant does not affect your ability to participate in the recovery.
Kessler Topaz Meltzer & Check, LLP encourages DENTSPLY investors who have suffered significant losses to contact the firm directly for more information.
CLICK HERE TO APPLY FOR A CASE OR GO TO: https://www.ktmc.com/new-cases/dentsply-sirona-inc?utm_source=PR&utm_medium=link&utm_campaign=xray&mktm=r
ABOUT KESSLER TOPAZ MELTZER & CHECK, LLP:
Kessler Topaz Meltzer & Check, LLP litigates class actions in state and federal courts nationwide and around the world. The company has built a global reputation for excellence and has recovered billions of dollars from victims of fraud and other corporate wrongdoing. All of our work is driven by a common goal: to protect investors, consumers, employees and others from fraud, abuse, misconduct and negligence by companies and fiduciaries. The appeal in this action was not filed by Kessler Topaz Meltzer & Check, LLP. For more information about Kessler Topaz Meltzer & Check, LLP, visit www.ktmc.com.
CONTACT:
Kessler Topaz Meltzer & Check, LLP
Jonathan Naji, Esq.
(484) 270-1453
280 King of Prussia Road
Radnor, PA 19087
info@ktmc.com
May be considered solicitor advertising in certain jurisdictions. Past results do not guarantee future results.
See the original release at www.newmediawire.com
Copyright 2024 JCN Newswire. All rights reserved.
